Hospital and Healthcare Real Estate: India's Next Big CRE Growth Sector

India's healthcare infrastructure is massively under-built relative to its population, income growth trajectory, and disease burden. With 1.4 beds per 1,000 population against a WHO recommendation of 3.0 (and a developed market average of 4–5), India needs to add over 3 million hospital beds over the next decade — implying real estate investment of ₹10–₹15 lakh crore in healthcare facilities. For commercial real estate investors who can navigate the sector's unique operating dynamics, healthcare real estate represents one of the most durable growth opportunities in Indian commercial property.

Hospital real estate in India operates under several structural advantages. Demand is driven by demographics (ageing population, rising non-communicable disease burden), income growth (expanding middle class accessing private healthcare for the first time), and insurance penetration (Ayushman Bharat and private health insurance are expanding the addressable market). Unlike office or retail, hospital demand does not fluctuate with technology trends or economic cycles — it grows relentlessly as population and income increase.

The major hospital chains — Apollo Hospitals, Fortis Healthcare, Max Healthcare, Manipal Hospitals, and Aster DM Healthcare — have historically owned their properties, conflating capital-intensive real estate ownership with healthcare operations. This is changing. Under pressure from private equity backers to maximise return on invested capital, Indian hospital chains are increasingly pursuing sale-leaseback strategies — selling hospital buildings to institutional investors and leasing them back under long-term agreements. Apollo Hospitals has completed several such transactions, and the model has attracted interest from Blackstone, HealthCo (a listed Australian healthcare REIT), and Indian family offices.

The operational complexity of hospital real estate — specialised MEP infrastructure, regulatory approvals, fire safety, infection control — creates significant barriers to entry for generalist developers but also supports premium yields (9–12% cap rates) and long lease terms (15–25 years) that make healthcare real estate exceptionally attractive for patient capital with the right operational partners.